提亚米拉尔血清度用于耐火性性状态,同时伴随着同时服用抗药物的度下降:一个病例报告
Kazutaka Oda1, Tomomi Katanoda2, Hitomi Arakaki3
1Department of Pharmacy, Kumamoto University Hospital, 1-1-1Chuo-Ku, Kumamoto City, HonjoKumamoto, Japan. kazutakaoda1980@gmail.com.
Journal of pharmaceutical health care and sciences
|July 12, 2024
概括
提亚米拉尔有效治疗了耐火状态 (RSE). 然而,它显著降低了卡巴马西平水平,需要在治疗期间密切监测抗药物 (AED) 度.
科学领域:
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- 耐火状态 (RSE) 是一个重大的治疗挑战.
- 蒂亚米拉尔是一种潜在的二线或三线治疗RSE.
- 蒂亚米拉尔诱导细胞染色体P450 (CYP) 活性可能会改变同时服用的抗药物 (AED) 度.
研究的目的:
- 报告一个用胺治疗的RSE病例.
- 为了监测蒂亚米拉尔和并发AED度.
- 评估蒂亚米拉尔对AED水平的临床影响.
主要方法:
- 一名72岁的RSE男性在其他AED失败后接受了蒂亚米拉尔.
- 蒂亚米拉尔是以玻尿酸剂的形式进行的,随后是连续输注.
- 在整个治疗过程中,药物度 (thiamylal,carbamazepine,其他AED) 被监测.
主要成果:
- 蒂亚米拉尔达到治疗度,并控制了发作.
- 同时的卡巴马西平度在提亚米拉尔输注期间显著下降.
- 在降低和停止小胺基剂量后,卡巴马齐平水平恢复;其他AEDs显示影响较小.
结论:
- 蒂亚米拉尔在管理RSE方面表现出有效性.
- 密切监测AED度,特别是卡巴马西平,在治疗胺时至关重要.
- 了解药物相互作用对于优化RSE治疗至关重要.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
380
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
380
Antiepileptic Drugs: Sodium Channel Blockers
497
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
497
Antiepileptic Drugs: Glutamate Antagonists
316
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
316
Antiepileptic Drugs: Potassium Channel Activators
165
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
165
Antiepileptic Drugs: Calcium Channel Blockers
362
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
362
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
284
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
284


